Mon, 26th Apr 2021 09:51
Hemogenyx Pharmaceuticals PLC - London-based biotechnology company - Receives convertible loan note conversion notice from Mint Capital Advisors Ltd. Notice is in respect to GBP900,000 worth of notes issued on February 3. Hemogenyx to issue 29.9 million shares at conversion price of GBP0.03015 each.
Current stock price: 2.94 pence, down 16% on Monday
Year-to-date change: down 70%
By Eric Cunha; ericcunha@alliancenews.com
Copyright 2021 Alliance News Limited. All Rights Reserved.
(Alliance News) - Hemogenyx Pharmaceuticals PLC on Thursday said it has raised GBP3.3 million through a placing.
(Alliance News) - Hemogenyx Pharmaceuticals PLC on Friday said research has shown that its proprietary chimeric bait receptor can be delivered into th...
(Alliance News) - Hemogenyx Pharmaceuticals PLC on Wednesday said its chimeric bait receptor can be delivered intranasally in the form of messenger RN...
Hemogenyx Pharmaceuticals PLC - London-based biopharmaceutical company focused on treatments for deadly blood diseases - US Food & Drug Administration...
Hemogenyx Pharmaceuticals PLC - London-based biopharmaceutical company focused on treatments for deadly blood diseases - Celebrates as patent applicat...
Hemogenyx (HEMO)